Spots Global Cancer Trial Database for correlative studies
Every month we try and update this database with for correlative studies cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery | NCT02144649 | Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | dietary interve... dietary interve... questionnaire a... Correlative stu... | 21 Years - | Ohio State University Comprehensive Cancer Center | |
| Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery | NCT02013492 | Male Breast Can... Recurrent Melan... Stage IV Breast... Stage IV Melano... Stage IV Ovaria... Stage IV Ovaria... Unspecified Adu... Hepatocellular ... | propranolol hyd... Correlative Stu... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | NCT02035527 | Metastatic Squa... Recurrent Metas... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Salivary Gland ... Stage IV Squamo... Stage IV Squamo... Stage IVA Saliv... Stage IVA Squam... Stage IVA Oral ... Stage IVA Squam... Stage IVA Squam... Stage IVA Verru... Stage IVA Verru... Stage IVB Saliv... Stage IVB Squam... Stage IVB Squam... Stage IVB Squam... Stage IVB Squam... Stage IVB Verru... Stage IVB Verru... Stage IVC Saliv... Stage IVC Squam... Stage IVC Squam... Stage IVC Squam... Stage IVC Squam... Stage IVC Verru... Stage IVC Verru... Tongue Cancer Untreated Metas... | sorafenib tosyl... cisplatin docetaxel Correlative Stu... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma | NCT02049541 | Extranodal Marg... Nodal Marginal ... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Splenic Margina... Waldenström Mac... | PI3K inhibitor ... rituximab Pharmacodynamic... Correlative stu... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma | NCT02049541 | Extranodal Marg... Nodal Marginal ... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Splenic Margina... Waldenström Mac... | PI3K inhibitor ... rituximab Pharmacodynamic... Correlative stu... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Central Pain Syndrome in Survivors of Head and Neck Cancer | NCT04128267 | Head and Neck C... | IPC-1000 Magnetic resona... Correlative Stu... | 21 Years - | Vanderbilt-Ingram Cancer Center | |
| Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery | NCT02144649 | Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | dietary interve... dietary interve... questionnaire a... Correlative stu... | 21 Years - | Ohio State University Comprehensive Cancer Center | |
| Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer | NCT00201773 | Breast Cancer | Exemestane Celecoxib Correlative stu... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors | NCT01713972 | Unspecified Adu... | dabrafenib pazopanib hydro... Correlative stu... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery | NCT02120222 | Recurrent Melan... | selinexor Correlative stu... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors | NCT01713972 | Unspecified Adu... | dabrafenib pazopanib hydro... Correlative stu... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer | NCT01652196 | Mucinous Adenoc... Mucinous Adenoc... Signet Ring Ade... Signet Ring Ade... Stage IV Colon ... Stage IV Rectal... | aflibercept oxaliplatin leucovorin fluorouracil Correlative Stu... DCE MRI f18FDG-PET PET (positron e... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery | NCT02120222 | Recurrent Melan... | selinexor Correlative stu... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery | NCT02013492 | Male Breast Can... Recurrent Melan... Stage IV Breast... Stage IV Melano... Stage IV Ovaria... Stage IV Ovaria... Unspecified Adu... Hepatocellular ... | propranolol hyd... Correlative Stu... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery | NCT02120222 | Recurrent Melan... | selinexor Correlative stu... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL | NCT02005289 | Contiguous Stag... Noncontiguous S... Prolymphocytic ... Recurrent Small... Refractory Chro... Stage I Chronic... Stage I Small L... Stage II Chroni... Stage III Chron... Stage III Small... Stage IV Chroni... Stage IV Small ... | MOR00208 lenalidomide Correlative Stu... | 18 Years - 80 Years | Ohio State University Comprehensive Cancer Center | |
| Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer | NCT01652196 | Mucinous Adenoc... Mucinous Adenoc... Signet Ring Ade... Signet Ring Ade... Stage IV Colon ... Stage IV Rectal... | aflibercept oxaliplatin leucovorin fluorouracil Correlative Stu... DCE MRI f18FDG-PET PET (positron e... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL | NCT02005289 | Contiguous Stag... Noncontiguous S... Prolymphocytic ... Recurrent Small... Refractory Chro... Stage I Chronic... Stage I Small L... Stage II Chroni... Stage III Chron... Stage III Small... Stage IV Chroni... Stage IV Small ... | MOR00208 lenalidomide Correlative Stu... | 18 Years - 80 Years | Ohio State University Comprehensive Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
